Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Processa Pharmaceuticals, Inc.
organization4 mentionslast seen Nov 5, 2026
Clinical stage biotechnology company focused on immunology drug development for autoimmune conditions.
Relationships 31
- Processa Pharmaceuticals, Inc.partners withGenerian Pharmaceuticals99% confidence3 sources
- Processa Pharmaceuticals, Inc.developsVT-720899% confidence3 sources
- Processa Pharmaceuticals, Inc.developsneonatal Fc receptor antagonist99% confidence3 sources
- Processa Pharmaceuticals, Inc.employsSheila Gujrathi99% confidence2 sources
- Processa Pharmaceuticals, Inc.acquiresVidya Therapeutics, Inc.99% confidence2 sources
- Processa Pharmaceuticals, Inc.employsAshley Hall99% confidence2 sources
- Processa Pharmaceuticals, Inc.employsCraig Coburn99% confidence2 sources
- Processa Pharmaceuticals, Inc.employsRussell Skibsted99% confidence2 sources
- Processa Pharmaceuticals, Inc.employsMichael P. Cruse99% confidence2 sources
- Processa Pharmaceuticals, Inc.acquiresVidya Therapeutics, Inc.99% confidence1 source
- Processa Pharmaceuticals, Inc.employsGregory J. Flesher98% confidence1 source
- Processa Pharmaceuticals, Inc.acquiresVidya Therapeutics, Inc.97% confidence1 source
- Processa Pharmaceuticals, Inc.employsGeorge Ng97% confidence1 source
- Processa Pharmaceuticals, Inc.employsGregory J. Flesher97% confidence1 source
- Processa Pharmaceuticals, Inc.funded byProcessa private placement financing96% confidence1 source
- Processa Pharmaceuticals, Inc.employsSheila Gujrathi96% confidence1 source
- Processa Pharmaceuticals, Inc.employsJustin Yorke95% confidence1 source
- Processa Pharmaceuticals, Inc.funded byProcessa private placement92% confidence1 source
- Janus Henderson Investorsinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- Octagon Capitalinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- Soleus Capitalinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- Bain Capital Life Sciencesinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- Cormorant Asset Managementinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- Integral Health Asset Managementinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- Marshall Waceinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- RA Capital Managementinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- SilverArc Capitalinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- ADAR1 Capital Managementinvests inProcessa Pharmaceuticals, Inc.85% confidence1 source
- Processa Pharmaceuticals, Inc.developsPCS1285280% confidence1 source
- Processa Pharmaceuticals, Inc.developsPCS11T80% confidence1 source
- Processa Pharmaceuticals, Inc.developsPCS49980% confidence1 source
Relationship
Processa Pharmaceuticals, Inc.employsCraig Coburn
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARNov 5, 2026Processa Pharmaceuticals, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Craig Coburn, Ph.D., as Executive Vice President, Head of Research
- filingSEC EDGARNov 4, 2026Processa Pharmaceuticals, Inc. 8-K: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Craig Coburn, Ph.D., Executive Vice President, Head of Research